Valuation: GSK plc

Market Cap 79.81B 107B 93.55B 86.37B 151B 10,213B 154B 1,038B 403B 4,998B 401B 392B 17,349B P/E 2026 *
12.9x
P/E 2027 * 11.8x
Enterprise Value 95.24B 127B 112B 103B 181B 12,187B 184B 1,239B 481B 5,964B 478B 468B 20,704B EV / Sales 2026 *
2.81x
EV / Sales 2027 * 2.59x
Free-Float
92.29%
Yield 2026 *
3.48%
Yield 2027 * 3.66%
1 day-1.72%
1 week+2.56%
Current month-0.08%
1 month+3.48%
3 months-6.85%
6 months+4.68%
Current year+8.50%
1 week 1,943
Extreme 1943
2,049
1 month 1,839
Extreme 1839
2,049
Current year 1,690
Extreme 1690
2,282
1 year 1,288.6
Extreme 1288.6047
2,282
3 years 1,242.5
Extreme 1242.5
2,282
5 years 1,242.5
Extreme 1242.5
3,408.16
10 years 1,242.5
Extreme 1242.5
3,408.16
Manager TitleAgeSince
Chief Executive Officer - 01/01/2026
Director of Finance/CFO 64 01/05/2023
Chief Tech/Sci/R&D Officer - 01/12/2021
Director TitleAgeSince
Director/Board Member - 06/05/2026
Director/Board Member 64 01/01/2018
Chairman 68 01/09/2019
Date Insider Type Main position Quantity % Market Cap.
06-22Buy

Executive/Senior Manager

9 0.0000%
06-08Buy

Executive/Senior Manager

9 0.0000%
05-22Buy

Executive/Senior Manager

9 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-1.17%+2.56%+39.99%+50.35% 107B
-1.02%+2.94%+57.75%+170.72% 1,102B
-0.54%+4.59%+70.51%+66.54% 643B
-0.38%+1.12%+33.78%+88.77% 450B
-1.35%+1.86%+29.96%+26.26% 336B
-0.71%+0.72%+28.85%+46.77% 288B
-1.31%-0.26%-28.18%-39.13% 222B
-0.09%+2.05%+24.16%+64.09% 199B
-0.96%+7.74%+22.20%+79.31% 169B
+0.31%+1.24%-5.64%-32.24% 137B
Average -0.75%+2.14%+27.34%+52.14% 365.19B
Weighted average by Cap. -0.75%+2.05%+40.63%+85.31%

Financials

2026 *2027 *
Net sales 33.86B 45.26B 39.69B 36.65B 64.19B 4,333B 65.47B 441B 171B 2,121B 170B 166B 7,361B 35.59B 47.56B 41.72B 38.51B 67.46B 4,554B 68.81B 463B 180B 2,229B 179B 175B 7,737B
Net income 6.47B 8.65B 7.59B 7.01B 12.27B 828B 12.52B 84.21B 32.72B 405B 32.49B 31.77B 1,407B 6.94B 9.27B 8.13B 7.51B 13.15B 888B 13.41B 90.27B 35.07B 434B 34.82B 34.06B 1,508B
Net Debt 15.43B 20.62B 18.09B 16.7B 29.25B 1,975B 29.83B 201B 78B 966B 77.44B 75.74B 3,354B 12.24B 16.35B 14.34B 13.24B 23.19B 1,566B 23.66B 159B 61.85B 766B 61.41B 60.06B 2,660B
Logo GSK plc
GSK plc is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows: - pharmaceutical products (41.3%): intended mainly for HIV infection (57% of net sales), immune system disorders and respiratory diseases (28.3%), and cancer (14.7%); - OTC and parapharmaceutical medicine (30.7%); - vaccines (28%). Net sales are distributed geographically as follows: the United Kingdom (2.1%), Europe (21%), the United States (51.6%), and other (25.3%).
Employees
66,841
Date Price Change Volume
08/07/26 GBX 1,979.50 -1.17% 3,794,960
07/07/26 GBX 2,003.00 +1.01% 4,183,855
06/07/26 GBX 1,983.00 -1.59% 15,158,597
03/07/26 GBX 2,015.00 +0.55% 2,548,759
02/07/26 GBX 2,004.00 +3.83% 17,567,408
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
21
Last Close Price
20.03GBP
Average target price
21.14GBP
Spread / Average Target
+5.55%

Quarterly revenue - Rate of surprise